Almost all of us have had a friend or relative taken away from the world by the scourge of cancer. Each of us fears the disease and the treatments needed to stop cancer’s insidious growth in the human body. Exasperated, we ask for a cure but know that there is no single cure for all cancers. But life-saving research is being done by dedicated, educated scientists who are daily discovering more about how cancers destroy bodies. Thankfully there are dedicated researchers like Clay Siegall searching for answers to this plague on modern man.
Clay Siegall has dedicated his life to fighting cancers. His undergraduate degree was earned in Zoology at the University of Maryland, and his Doctorate was achieved in genetics from George Washington University. Siegall put his education to work in the medical research field working for various institutions and firms. He worked from 1988 until 1991 at the National Cancer Institute, National Institutes of Health. He then was employed by the Bristol-Myers Squibb Pharmaceutical Research Institute from 1991 to 1997. While working for Bristol-Myers Squibb, he was in charge of a research investigation department located in Seattle. When the company sought to terminate operations in Seattle, Siegall who had formed a fondness for this part of Washington State decided to go out on his own.
Siegall founded his startup, Seattle Genetics, in 1998. The firm has received extensive investment funding, and with Siegall as the CEO, President, and a member of the Board of Directors there is no doubt that the firm will become one of the most important research firms seeking cures for cancers. As Seattle Genetics approaches profitability, the time for a takeover from a larger research firm may be imminent, but Siegall vows to remain at the helm and to explore to the best of his company’s ability the ways to find solutions to this dreaded disease.